3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
4
Tumor-Agnostic
3
Thoracic
3
Head & Neck
3
Genitourinary
3
Other solid neoplasm
2
Gynecologic
2
Breast
2
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Cyclophosphamide
9
ruxolitinib
7
Azacitidine
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Peripheral Blood Stem Cell Transplantation
6
Mycophenolic Acid
6
navitoclax
5
fludarabine
5
Therapeutics
5
Busulfan
5
ponatinib
4
Melphalan
4
Tacrolimus
3
Stem Cell Transplantation
3
Patient Reported Outcome Measures
3
Mesna
3
Immunoenzyme Techniques
3
Flow Cytometry
3
Cyclosporine
3
Clofarabine
3
Antilymphocyte Serum
3
vosaroxin
2
trametinib
2
liposomal amphotericin B
2
dabrafenib
2
Watchful Waiting
2
Transplantation
2
Sirolimus
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Immunotherapy
×
Myeloid
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled